Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Monte H4 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Monte H4

Approved

STANDARD

Monte H4

Hetero Labs Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 3faaf0745cabea99
Company: Hetero Labs Limited
Type: Standard

Approval Details

Approval Id: 3faaf0745cabea99
Drug Approval Philippines Name: Monte H4
Product Name: Monte H4
Registration Number: DRP-6894
Brand Name: Monte H4
Generic Name: Montelukast (As Sodium)
Dosage Form: Chewable Tablet
Dosage Strength: 4 mg
Manufacturer: Hetero Labs Limited
Importer: S.M.H.P. Marketing and Consultancy
Distributor: S.M.H.P. Marketing and Consultancy
Company Detail Path: /organization/hetero-labs-limited
Issuance Date: 26 May 2022
Expiry Date: 21 July 2027
Pharmacologic Category: Leukotriene Receptor Antagonist
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

3faaf0745cabea99

Type

Standard

Back to Philippines FDA Approvals